From: Prognostic impact of para-aortic lymph node metastases in non-pancreatic periampullary cancer
Variable | PALN+ | PALN– | P |
---|---|---|---|
Patients [n] | 7 | 60 | |
Median age [years] (IQR) | 67 (64–73) | 71 (63–75) | 0.798 |
Male sex [n/(%)] | 2 (29) | 35 (58) | 0.228 |
Diabetes [n/(%)] | 2 (29) | 8 (13) | 0.278 |
Weight loss [n/(%)] | 5 (71) | 27 (45) | 0.245 |
Jaundice [n/(%)] | 5 (71) | 32 (53) | 0.446 |
Median CA 19–9 [U/ml] (IQR) | 166 (28–530) | 46 (15–139) | 0.583 |
Operation [n/(%)] | |||
PPPD | 7 (100) | 50 (83) | 0.582 |
cPD | 0 | 9 (15) | 0.581 |
TP | 0 | 1 (2) | 1.000 |
Neoadj. therapy [n/(%)] | 0 | 0 | |
Portal vein resection [n/(%)] | 1 (14) | 11 (18) | 1.000 |
Median operative time [min] (IQR) | 375 (313–473) | 363 (298–439) | 0.573 |
Adjuvant therapy [n/(%)] | 4 (57) | 17 (28) | 0.193 |